FDA Approves Xadago to Treat Parkinsonís Disease

Share

(March 22, 2017) - U.S. regulators have approved the first new drug in a decade for Parkinson's disease, The Food and Drug Administration has approved Xadago for use when a patient's regular medicines aren't working well. Newron Pharmaceuticals developed Xadago, known chemically as safinamide and its partner in the U.S., US Worldwide Meds, will market Xadago in this country. Read more…

Click for a printer friendly version

Back to top